Product Information
ZIPRASIDONE HCL 40 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2671 per EA under NDC 65862070360. Its NADAC has been published 479 times since Jun 21, 2017.
FDA first approved this application on Dec 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862070360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ZIPRASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204117FDA Approved
12/27/2016
TE Code
AB
On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has been published 479 times since Jun 21, 2017, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2671 per EA |
|---|---|
| All-time high | $0.5722 (Jul 12, 2017) |
| All-time low | $0.1879 (Nov 20, 2024) |
| 52-week high | $0.2786 |
| 52-week low | $0.2548 |
| Median price | $0.2983 |
| Average price | $0.3220 |
| Largest weekly change | +41.5% (Sep 23, 2020) |
| Weeks tracked | 479 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIPRASIDONE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 40 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2671 per EA (NDC 65862070360), effective Aug 19, 2026.
How has the price of ZIPRASIDONE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has declined 53.3%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 40 MG CAPSULE?
Since Jun 21, 2017, the NADAC for ZIPRASIDONE HCL 40 MG CAPSULE has ranged from a low of $0.1879 (Nov 20, 2024) to a high of $0.5722 (Jul 12, 2017), with a median of $0.2983 per EA.
Are there cheaper alternatives to ZIPRASIDONE HCL 40 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZIPRASIDONE HCL 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ZIPRASIDONE HCL 40 MG CAPSULE?
ZIPRASIDONE HCL 40 MG CAPSULE (NDC 65862070360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.